BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
RYAN
Ryan Specialty Holdings, Inc.
There isn't enough reported data to score RYAN yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RYAN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
RYAN's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like RYAN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
RYAN PE Valuation
RYAN has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
RYAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for RYAN, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus RYAN down 71%.
RYAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.35 | +2037% |
| Q4 2025 | $0.11 | -71% |
| Q3 2025 | $0.13 | -75% |
| Q2 2025 | $0.12 | -68% |
| Q1 2025 | $0.10 | -78% |
| Q4 2024 | $0.38 | -45% |
| Q3 2024 | $0.51 | -24% |
| Q2 2024 | $0.37 | -55% |
| Q1 2024 | $0.46 | -41% |
RYAN's earnings per share have fallen from their peak: $0.11 over the past year, against $0.82 in mid-2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
RYAN has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 14% for RYAN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over RYAN on profitability, with a higher operating margin.
RYAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790M | +4.7% |
| Q4 2025 | $751.2M | +13% |
| Q3 2025 | $754.6M | +25% |
| Q2 2025 | $855.2M | +23% |
| Q1 2025 | $690.2M | +25% |
| Q4 2024 | $663.5M | +25% |
| Q3 2024 | $604.7M | +20% |
| Q2 2024 | $695.4M | +19% |
RYAN's revenue has grown year over year every quarter since early 2021: $790M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -2.8 points |
| Q4 2025 | 18% | +7.6 points |
| Q3 2025 | 21% | +17 points |
| Q2 2025 | 16% | -3.6 points |
| Q1 2025 | 7.4% | -1.1 points |
| Q4 2024 | 10% | -0.7 points |
| Q3 2024 | 3.3% | -4.8 points |
| Q2 2024 | 20% | +3.4 points |
RYAN's operating margin was 18% last quarter, up 10 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
RYAN has the stronger cash trend. Its trailing FCF is up 176% versus its history, compared with BAC at up 119%.
RYAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $181.3M | +17% |
| Q4 2025 | $246M | +1.5% |
| Q3 2025 | $155.5M | +66% |
| Q2 2025 | $333.8M | +30% |
| Q1 2025 | -$159.6M | -$35.4M |
| Q4 2024 | $242.3M | +14% |
| Q3 2024 | $93.8M | -1.1% |
| Q2 2024 | $255.9M | -15% |
RYAN's free cash flow was $917M over the past year, up 112% from the year before. Free cash flow isn't a meaningful measure for financial services companies like RYAN.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RYAN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RYAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.7% | -26.9M shares |
| 1 year | +100% | +126M shares |
| 3 years | +127% | +141M shares |
| 5 years | +136% | +145M shares |
RYAN has 252M diluted shares, up 100% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150.1M |
| Q4 2025 | $3.5M |
| Q3 2025 | $82,000 |
| Q2 2025 | $13M |
| Q1 2025 | $1.7M |
| Q4 2024 | $83,000 |
| Q3 2024 | $82,000 |
| Q2 2024 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RYAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 4.2x | High |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 4.8x | High |
| Q1 2025 | 5.5x | High |
| Q4 2024 | 4.9x | High |
| Q3 2024 | 4.9x | High |
| Q2 2024 | 2.9x | Moderate |
| Q1 2024 | 3.1x | Elevated |
RYAN's net debt is about 4.2 years of its operating earnings (EBITDA), down from 4.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like RYAN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RYAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 78.4 | Neutral |
RYAN's weekly RSI is 59 (neutral) and its Stochastic is 78 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
RYAN PE vs Financial Services Sector
| Metric | RYAN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
RYAN has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RYAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.8 | 10% above |
| 20 week MA | $41.9 | 10% above |
| 50 week MA | $41.0 | 12% above |
| 100 week MA | $52.3 | 12% below |
| 200 week MA | $51.7 | 11% below |
RYAN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over RYAN on returns for 2026, with the stronger performance.
RYAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.6 | $39.3 | +38% |
| 2022 | $39.3 | $40.6 | +3.1% |
| 2023 | $40.6 | $43.0 | +6.1% |
| 2024 | $43.0 | $64.0 | +49% |
| 2025 | $64.0 | $51.8 | -19% |
| 2026 YTD | $51.8 | $46.2 | -11% |
RYAN has finished higher in four of the last five years. It's down 11% so far in 2026.